Identification of a discrete population of human bone marrow-derived mesenchymal cells exhibiting properties of uncommitted progenitors

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Cellular Therapy

Background:

• Mesenchymal progenitor cells (MPC) derived from human bone marrow exhibit heterogeneity after ex vivo expansion.
• Proliferative potential and differentiation stages vary significantly among expanded MPC populations.

Purpose of the Study:

• To identify and characterize a quiescent, uncommitted progenitor cell population within ex vivo-expanded bone marrow-derived MPC.
• To evaluate the therapeutic potential of these identified progenitor cells.

Main Methods:

• Ex vivo expansion of human bone marrow-derived MPC.
• Induction of metabolic death in proliferative MPC using 5-fluorouracil.
• Isolation and characterization of the remaining quiescent cell subset.
• Assessment of self-renewal and lineage commitment (adipogenic, osteogenic).
• In vivo engraftment studies (bone marrow, spleen, bone, skeletal muscle).
• Evaluation of adenoviral vector transduction efficiency.

Main Results:

• Exposure to 5-fluorouracil selectively eliminated proliferative MPC, revealing a quiescent subset (5-20%).
• This isolated subset comprises uncommitted, undifferentiated mesenchymal cells capable of self-renewal.
• These cells generate precursors committed to adipogenic and osteogenic lineages.
• The identified cells engraft in various tissues including bone marrow, spleen, bone, and skeletal muscle after intravenous infusion.
• Efficient transduction with adenoviral vectors was demonstrated.

Conclusions:

• A discrete population of uncommitted mesenchymal progenitor cells exists within ex vivo-expanded bone marrow-derived MPC.
• These progenitor cells possess self-renewal capacity and multipotent differentiation potential.
• Their engraftment ability and amenability to gene transduction position them as a promising candidate for cellular and gene therapies targeting mesenchymal tissue disorders.